$IMG
Stock $img

$img Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224021335 Filed on May 24, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$605.8K	$781.2K
YoY Change	-22.45%	9.24%
Cost Of Revenue	$752.0K	$744.5K
YoY Change	1.0%	4.26%
Gross Profit	-$146.2K	$36.63K
YoY Change	-499.21%	3637.76%
Gross Profit Margin	-24.14%	4.69%
Selling, General & Admin	$86.64K	$38.17K
YoY Change	126.98%
% of Gross Profit		104.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$68.21K	$38.83K
YoY Change	75.66%	-70.0%
% of Gross Profit		106.01%
Operating Expenses	$1.465M	$1.983M
YoY Change	-26.14%	-37.97%
Operating Profit	-$1.611M	-$1.946M
YoY Change	-17.24%	-39.09%
Interest Expense	-$550.00	$5.350K
YoY Change	-110.28%	-250.28%
% of Operating Profit
Other Income/Expense, Net	-$42.63K	-$26.92K
YoY Change	58.36%	9.21%
Pretax Income	-$1.654M	-$1.968M
YoY Change	-15.95%	-38.96%
Income Tax
% Of Pretax Income
Net Earnings	-$1.654M	-$1.968M
YoY Change	-15.95%	-38.96%
Net Earnings / Revenue	-273.03%	-251.91%
Basic Earnings Per Share	-$1.28	-$2.80
Diluted Earnings Per Share	-$1.28	-$2.80
COMMON SHARES
Basic Shares Outstanding	1.282M shares	691.1K shares
Diluted Shares Outstanding	1.295M shares	702.9K shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$4.699M
YoY Change	-100.0%	-42.77%
Cash & Equivalents		$4.699M
Short-Term Investments
Other Short-Term Assets	$382.8K	$301.4K
YoY Change	27.03%	-70.23%
Inventory	$1.208M	$1.230M
Prepaid Expenses
Receivables	$397.6K	$421.6K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.989M	$6.652M
YoY Change	-70.1%	-36.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$522.6K	$402.8K
YoY Change	29.73%	-73.55%
Goodwill
YoY Change
Intangibles	$95.00K	$125.0K
YoY Change	-24.0%
Long-Term Investments	$160.1K	$166.1K
YoY Change	-3.61%	-4.04%
Other Assets	$72.91K	$87.22K
YoY Change	-16.41%	-17.21%
Total Long-Term Assets	$1.228M	$1.300M
YoY Change	-5.55%	-51.05%
TOTAL ASSETS
Total Short-Term Assets	$1.989M	$6.652M
Total Long-Term Assets	$1.228M	$1.300M
Total Assets	$3.217M	$7.952M
YoY Change	-59.55%	-39.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.613M	$210.2K
YoY Change	1143.24%	-74.95%
Accrued Expenses	$295.5K	$756.7K
YoY Change	-60.94%	43.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$291.5K	$38.41K
YoY Change	658.92%	-21.9%
Total Short-Term Liabilities	$3.534M	$1.778M
YoY Change	98.81%	-13.29%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$6.870K
YoY Change	-100.0%	-84.94%
Other Long-Term Liabilities	$256.3K	$81.13K
YoY Change	215.93%	-86.32%
Total Long-Term Liabilities	$257.4K	$230.8K
YoY Change	11.56%	-63.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.534M	$1.778M
Total Long-Term Liabilities	$257.4K	$230.8K
Total Liabilities	$3.792M	$2.009M
YoY Change	88.78%	-25.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$77.17M	-$68.77M
YoY Change	12.22%
Common Stock	$76.43M	$74.56M
YoY Change	2.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$574.9K	$5.944M
YoY Change
Total Liabilities & Shareholders Equity	$3.217M	$7.952M
YoY Change	-59.55%	-39.57%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$1.654M	-$1.968M
YoY Change	-15.95%	-38.96%
Depreciation, Depletion And Amortization	$68.21K	$38.83K
YoY Change	75.66%	-70.0%
Cash From Operating Activities	-$661.0K	-$1.737M
YoY Change	-61.94%	-32.53%
INVESTING ACTIVITIES
Capital Expenditures	-$800.00	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	$800.00	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	219.9K	-12.70K
YoY Change	-1831.73%	-103.5%
NET CHANGE
Cash From Operating Activities	-661.0K	-1.737M
Cash From Investing Activities	800.0	0.000
Cash From Financing Activities	219.9K	-12.70K
Net Change In Cash	-440.3K	-1.750M
YoY Change	-74.83%	-36.34%
FREE CASH FLOW
Cash From Operating Activities	-$661.0K	-$1.737M
Capital Expenditures	-$800.00	$0.00
Free Cash Flow	-$660.2K	-$1.737M
YoY Change	-61.99%	-27.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	382830	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	522607	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	377475	usd
CY2024Q1	us-gaap	Investments Investments	160136	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	95000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	72908	usd
CY2024Q1	us-gaap	Assets Assets	3216876	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2613314	usd
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	280752	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	295544	usd
CY2024Q1	us-gaap	Deferred Income Current DeferredIncomeCurrent	305432	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	28534	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3534327	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1135	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1805352	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	36630	usd
	us-gaap	Gross Profit GrossProfit	29050	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1653931	usd
CY2024Q1	us-gaap	Cash Cash		usd
CY2022Q4	NUZE	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
	NUZE	Proceeds From Sales Of Future Receipts ProceedsFromSalesOfFutureReceipts		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	NUZE	Proceeds From Equipment Finance ProceedsFromEquipmentFinance		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	NUZE	Forgiveness Of Stock Issuance Costs ForgivenessOfStockIssuanceCosts		usd
CY2024Q1	us-gaap	Cash Cash		usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths		usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2024Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross		usd
CY2023Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q3	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding		usd
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Exercisable Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsExercisableAggregateIntrinsicValueNonvested		usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	418200	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1988750	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	3376249	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	309555	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	403258	usd
CY2023Q3	us-gaap	Investments Investments	162259	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	110000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	79677	usd
CY2024Q1	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	705519	usd
CY2023Q3	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	755194	usd
CY2023Q3	us-gaap	Assets Assets	4440998	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1903923	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent	4753	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	216128	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	10751	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	26048	usd
CY2023Q3	us-gaap	Deferred Income Current DeferredIncomeCurrent	379795	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	25756	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2556403	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162301	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	256311	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	47937	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	257446	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	210238	usd
CY2024Q1	us-gaap	Liabilities Liabilities	3791773	usd
CY2023Q3	us-gaap	Liabilities Liabilities	2766641	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1298414	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1298414	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	748644	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	748644	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	13	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	8	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	76428560	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	74925843	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-77174529	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-73371987	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	171059	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	120493	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-574897	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1674357	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3216876	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4440998	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	605761	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	781166	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1959748	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1917514	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	751990	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	744536	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1930698	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-146229	usd
	us-gaap	Gross Profit GrossProfit	112162	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1464523	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1982929	usd
	us-gaap	Operating Expenses OperatingExpenses	3782757	usd
	us-gaap	Operating Expenses OperatingExpenses	4260129	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1610752	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1946299	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3753707	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4147967	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-72	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1673	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2123	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3497	usd
CY2024Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	33675	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	62464	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	80686	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	113202	usd
CY2024Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	76300	usd
CY2023Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	89387	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	126400	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	125177	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-482	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7022	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-998	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12360	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1653931	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1967873	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3802542	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4151079	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.28
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.28
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.80
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.80
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.02
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1295445	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1295445	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	702862	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	702862	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1231485	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1231485	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	689550	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	689550	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1653931	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1967873	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	8158	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-42965	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8158	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-42965	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1645773	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2010838	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3802542	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4151079	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	50566	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	72618	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	50566	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	72618	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3751976	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4078461	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1674357	usd
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1277118	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	11505	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	129662	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	42408	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-2148611	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	986439	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	54443	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	29994	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8158	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-574897	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9742799	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	197108	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	62839	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	115583	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-2183206	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7935123	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7935123	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	57120	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	25000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-114482	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	51940	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-42965	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1967873	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5943863	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5943863	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3802542	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4151079	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	108189	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	112637	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	131608	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	123505	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	65948	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	82626	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	57120	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	114779	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	67003	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-41108	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2123	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3497	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-189295	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	143313	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	210267	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	281908	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-35370	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-246393	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-6769	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	9261	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	807383	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	96494	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-74363	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2570	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-187575	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-136330	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-95214	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	109138	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	26060	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	14646	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2997216	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3650375	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	306241	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16514	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-306241	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16514	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	190675	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	3939	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	15297	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	17616	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	191094	usd
	NUZE	Proceeds From Sales Of Future Receipts ProceedsFromSalesOfFutureReceipts	195001	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	159656	usd
	NUZE	Proceeds From Equipment Finance ProceedsFromEquipmentFinance	262893	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1099254	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	177864	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1879790	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21555	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	50566	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	72618	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1373101	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3615826	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1373101	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8315053	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4699227	usd
	us-gaap	Interest Paid Net InterestPaidNet	1338	usd
	us-gaap	Interest Paid Net InterestPaidNet	2034	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2618	usd
	NUZE	Forgiveness Of Stock Issuance Costs ForgivenessOfStockIssuanceCosts	25000	usd
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	ratio from 1-for-10 to 1-for-50
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-35
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	241907	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	256291	shares
CY2024Q1	NUZE	Working Capital WorkingCapital	-1545577	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zqXpxFsQBiD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zfhGctNuXSmg">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zA3lIamvzqzi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zHbY1RQ0nJqj">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company places its cash with high quality banking institutions. From time to time, the Company may or may not maintain cash balances at certain institutions in excess of the Federal Deposit Insurance Corporation limit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	58636	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	58636	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y6M
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	403258	usd
	NUZE	Addition For Right Of Use Of Assets AdditionForRightOfUseOfAssets	105825	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	131608	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	377475	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	378429	usd
	NUZE	Addition For Lease Liability AdditionForLeaseLiability	105825	usd
	NUZE	Operating Lease Lease Liability Amortization Expense OperatingLeaseLeaseLiabilityAmortizationExpense	187575	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	296679	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	295544	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1135	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	296679	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	141512	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	88430	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	229942	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	66737	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	296679	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	295544	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1135	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1303	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	11038	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	11038	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	287	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	10751	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	10751	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	124553	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1303	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	15297	usd
	us-gaap	Sublease Income SubleaseIncome	76742	usd
CY2024Q1	NUZE	Sub Lease Liability Payments Due Next Twelve Months SubLeaseLiabilityPaymentsDueNextTwelveMonths	32459	usd
CY2024Q1	NUZE	Minimum Lease Payments To Be Received Sublease MinimumLeasePaymentsToBeReceivedSublease	32459	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	50566	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	72618	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2123	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3497	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	382830	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	418200	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	382830	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	418200	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	1208337	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	998070	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1188118	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	982626	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	20219	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	15444	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	1208337	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	998070	usd
	us-gaap	Depreciation Depreciation	108189	usd
	us-gaap	Depreciation Depreciation	112637	usd
	NUZE	Property And Equipment Description PropertyAndEquipmentDescription	Expenditures associated with upgrades and enhancements that improve, add functionality, or otherwise extend the life of property and equipment that exceed $1,000 are capitalized.
CY2024Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2273264	usd
CY2023Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1895859	usd
CY2024Q1	us-gaap	Public Utilities Property Plant And Equipment Vehicles PublicUtilitiesPropertyPlantAndEquipmentVehicles	68420	usd
CY2023Q3	us-gaap	Public Utilities Property Plant And Equipment Vehicles PublicUtilitiesPropertyPlantAndEquipmentVehicles	73980	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1819077	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1660284	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	522607	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	309555	usd
	NUZE	Purchase Of Deposit Equipment PurchaseOfDepositEquipment	0	usd
CY2023	NUZE	Purchase Of Deposit Equipment PurchaseOfDepositEquipment	0	usd
CY2024Q1	NUZE	Accounts Receivable Face Discount Percentage AccountsReceivableFaceDiscountPercentage	0.03	pure
	NUZE	Repaid Advances Amount RepaidAdvancesAmount	153889	usd
	NUZE	Repaid Advances Discount Percentage RepaidAdvancesDiscountPercentage	0.03	pure
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	262893	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1959748	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1917514	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	522607	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	309555	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	95000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	30000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	15000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	30000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	30000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	20000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	95000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	96458	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	150.39
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M2D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	13425	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	100.11
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Forfeited And Expired Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingForfeitedAndExpiredWeightedAverageRemainingContractualTerm2	P0Y21D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	83033	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	158.85
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y9M25D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	60731	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	187.43
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y25D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	24029	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	80.73
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	1715	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	63.04
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	12	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	587.65
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	22302	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	81.82
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	152398	shares
CY2023Q3	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1	158.24
CY2023	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm	P2Y7M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	6476	shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Granted In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantedInPeriodWeightedAverageExercisePrice	2.64
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	158874	shares
CY2024Q1	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1	151.90
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm	P2Y3M
	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	158874	shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercisable In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisableInPeriodWeightedAverageExercisePrice	151.90
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTermExercisable	P2Y3M
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_802_eus-gaap--LossContingencyDisclosures_zzG59574O7li" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.<span id="xdx_827_zXqQchGnU7a8"> CONTINGENCY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Steeped, Inc. Litigation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 27, 2023, Steeped, Inc. d/b/a Steeped Coffee (“Steeped”) filed a complaint against the Company in the Superior Court of California, Santa Cruz County (Case No. 23CV00234) (the “Steeped Litigation”). The Steeped Litigation relates to Steeped’s claim that the Company breached a 2021 settlement agreement that resolved Steeped’s 2019 trademark infringement case against the Company. The earlier case involved Steeped’s purported trademark protection for “steeped coffee” and related phrases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steeped’s operative complaint in the pending Steeped Litigation alleges breach of contract, intentional interference with contractual relations, intentional interference with prospective economic advantage, and fraud in the inducement of contract. Plaintiff seeks a trial by jury and relief in the form of a permanent injunction for use of “Steep Coffee” or any confusingly similar variant of “STEEPED COFFEE”; the impoundment and destruction of allegedly violating packaging materials and/or finished goods; a final judgment for all profits derived from the Company’s allegedly unlawful conduct, actual damages, damages to the Plaintiff’s reputation and goodwill among its customers and partners; and reasonable attorneys’ fees and costs. NuZee answered Steeped’s complaint with a general denial and asserted twenty-five affirmative defenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 16, 2024, a mediation hearing was held. After the close of business, the mediator suggested a settlement amount of $<span id="xdx_900_eus-gaap--LossContingencyDamagesAwardedValue_c20240116__20240116_z2i92ukx3rR5" title="Settlement amount">500,000</span> which both parties agreed to accept. While the amount was agreed to, a payment schedule was not agreed on. Negotiations between the parties to establish an acceptable payment schedule are ongoing. The settlement amount is accrued in the financial statements as of March 31, 2024 and is included in current liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Curtin Litigation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 6, 2023, a former employee of the Company, Rosaline Curtin (“Ms. Curtin”), filed a complaint against the Company and another former employee of the Company, Jose Ramirez (“Mr. Ramirez”), in the Superior Court of California, County of San Diego (Case No. 37-2023-00000841-CU-WT-NC) (the “Curtin Complaint”). The Curtin Complaint alleges that Ms. Curtin was subject to harassment by her supervisor, Mr. Ramirez, and gender discrimination throughout her employment, that she reported this discrimination and harassment to the Company, and that the Company retaliated against her and wrongfully terminated her for whistleblowing and failed to prevent discrimination, harassment, and retaliation. The Curtin Complaint seeks compensatory damages, including loss of past, present and future earnings, and benefits, as well as punitive damages, penalties, attorney’s fees and costs and interest. The Company has responded to the complaint on behalf of the Company and Mr. Ramirez and prevailed on December 22, 2023, prevailed on its motion to compel. Arbitration proceedings have been initiated, and the parties have agreed on an arbitrator. A date for the arbitration hearing has not yet been scheduled. We believe the allegations set forth in the Curtin Complaint are without merit and intend to defend vigorously against the allegations. However, the Company is not able to predict the outcome, and there is no assurance that the Company will be successful in its defense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, we may be subject to legal proceedings and claims in the ordinary course of business. The results of any future litigation cannot be predicted with certainty, and, regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors. Matters that are probable of unfavorable outcomes to us and which can be reasonably estimated are accrued. Such accruals are based on information known about the matters, our estimates of the outcomes of such matters and our experience in contesting, litigating and settling similar matters.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	500000	usd
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-021335-index-headers.html	Edgar Link	pending
0001493152-24-021335-index.html	Edgar Link	pending
0001493152-24-021335.txt	Edgar Link	pending
0001493152-24-021335-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nuze-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
nuze-20240331_def.xml	Edgar Link	unprocessable
nuze-20240331_lab.xml	Edgar Link	unprocessable
nuze-20240331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nuze-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IMG
Stock $img

2024 Q1 Form 10-Q Financial Statement

#000149315224021335 Filed on May 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMG Stock $img

2024 Q1 Form 10-Q Financial Statement

#000149315224021335 Filed on May 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMG
Stock $img